CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Economic Benefits of Intensive Insulin Therapy in Critically Ill Patients: The Targeted Insulin Therapy to Improve Hospital Outcomes (TRIUMPH) Project
Authors
A. C. Ang
A. R. Sadhu
+19 more
Almbrand
Clement
D. S. Martinez
Estrada
Furnary
Garber
Goldman
Hodgson
Krinsley
L. A. Ingram-Drake
Malmberg
Markovitz
S. L. Ettner
van den Berghe
Van den Berghe
Van den Berghe
W. A. Hsueh
Williams
Zweig
Publication date
Publisher
American Diabetes Association
Doi
View
on
PubMed
Abstract
OBJECTIVE—The purpose of this study was to analyze the economic outcomes of a clinical program implemented to achieve strict glycemic control with intensive insulin therapy in patients admitted to the intensive care unit (ICU)
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 11/12/2019